98 related articles for article (PubMed ID: 25854429)
1. A new and practical synthetic method for the synthesis of 6-O-methyl-scutellarein: one metabolite of scutellarin in vivo.
Lin H; Zhang W; Dong ZX; Gu T; Li NG; Shi ZH; Kai J; Qu C; Shang GX; Tang YP; Fang F; Li HM; Yang JP; Duan JA
Int J Mol Sci; 2015 Apr; 16(4):7587-94. PubMed ID: 25854429
[TBL] [Abstract][Full Text] [Related]
2. A new and efficient synthesis of 6-O-methylscutellarein, the major metabolite of the natural medicine scutellarin.
Zhang W; Dong ZX; Gu T; Li NG; Zhang PX; Wu WY; Yu SP; Tang YP; Yang JP; Shi ZH
Molecules; 2015 Jun; 20(6):10184-91. PubMed ID: 26042857
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of methylated scutellarein analogs based on metabolic mechanism of scutellarin in vivo.
Shi ZH; Li NG; Wang ZJ; Tang YP; Dong ZX; Zhang W; Zhang PX; Gu T; Wu WY; Yang JP; Duan JA
Eur J Med Chem; 2015 Dec; 106():95-105. PubMed ID: 26523667
[TBL] [Abstract][Full Text] [Related]
4. Isolation and identification of ten metabolites of breviscapine in rat urine.
Xia H; Qiu F; Zhu S; Zhang T; Qu G; Yao X
Biol Pharm Bull; 2007 Jul; 30(7):1308-16. PubMed ID: 17603172
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of 6-O-methyl-scutellarein on repeated cerebral ischemia/reperfusion in rats.
Wu WY; Zhong Y; Lu YT; Sun Y; Li NG; Shi ZH; Dong ZX; Gu T; Xue X; Fang F; Li HM; Tang YP; Duan JA
J Asian Nat Prod Res; 2018 Dec; 20(12):1167-1181. PubMed ID: 28971689
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of glucose-containing scutellarein derivatives as neuroprotective agents based on metabolic mechanism of scutellarin in vivo.
Li NG; Shen MZ; Wang ZJ; Tang YP; Shi ZH; Fu YF; Shi QP; Tang H; Duan JA
Bioorg Med Chem Lett; 2013 Jan; 23(1):102-6. PubMed ID: 23177255
[TBL] [Abstract][Full Text] [Related]
7. Two major urinary metabolites of scutellarin in rats.
Qiu F; Xia H; Zhang T; Di X; Qu G; Yao X
Planta Med; 2007 Apr; 73(4):363-5. PubMed ID: 17354170
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
Huang JM; Weng WY; Huang XB; Ji YH; Chen E
Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
[TBL] [Abstract][Full Text] [Related]
9. Dual Effect of Glucuronidation of a Pyrogallol-Type Phytophenol Antioxidant: A Comparison between Scutellarein and Scutellarin.
Liu Q; Li X; Ouyang X; Chen D
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563286
[TBL] [Abstract][Full Text] [Related]
10. An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin.
Dong ZX; Li NG; Zhang PX; Gu T; Wu WY; Shi ZH
Molecules; 2016 Feb; 21(3):263. PubMed ID: 26927039
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and bio-activity evaluation of scutellarein as a potent agent for the therapy of ischemic cerebrovascular disease.
Qian LH; Li NG; Tang YP; Zhang L; Tang H; Wang ZJ; Liu L; Song SL; Guo JM; Ding AW
Int J Mol Sci; 2011; 12(11):8208-16. PubMed ID: 22174659
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of scutellarin and apigenin 7-O-β-d-glucuronide.
Liu X; Wen GE; Liu JC; Liao JX; Sun JS
Carbohydr Res; 2019 Mar; 475():69-73. PubMed ID: 30877936
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthesis of scutellarein.
Righi G; Silvestri IP; Barontini M; Crisante F; Di Manno A; Pelagalli R; Bovicelli P
Nat Prod Res; 2012; 26(14):1278-84. PubMed ID: 22007873
[TBL] [Abstract][Full Text] [Related]
14. [Advances in studies on pharmacokinetics of scutellarin and scutellarein].
Liu J; Xiong Y
Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3165-8. PubMed ID: 20352990
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC-MS/MS for pharmacokinetic study of breviscapine.
Wang X; Xia H; Liu Y; Qiu F; Di X
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():79-84. PubMed ID: 24999248
[TBL] [Abstract][Full Text] [Related]
16. Breviscapine: A Review on its Phytochemistry, Pharmacokinetics and Therapeutic Effects.
Wen L; He T; Yu A; Sun S; Li X; Wei J; Song R; Yan X; Li R; Ren X; Wang Y; Liu X; Dong Y; Fu X; She G
Am J Chin Med; 2021; 49(6):1369-1397. PubMed ID: 34263720
[TBL] [Abstract][Full Text] [Related]
17. Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2.
You L; Zhu H; Wang C; Wang F; Li Y; Li Y; Wang Y; He B
Bioorg Med Chem Lett; 2017 Dec; 27(24):5404-5408. PubMed ID: 29157862
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic Mechanism In Vivo.
Dong ZX; Shi ZH; Li NG; Zhang W; Gu T; Zhang PX; Wu WY; Tang YP; Fang F; Xue X; Li HM; Cheng HB; Yang JP; Duan JA
Chem Biol Drug Des; 2016 Jun; 87(6):946-57. PubMed ID: 26808289
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of scutellarein derivatives to increase biological activity and water solubility.
Shi ZH; Li NG; Shi QP; Zhang W; Dong ZX; Tang YP; Zhang PX; Gu T; Wu WY; Fang F; Xin-Xue ; Li HM; Yang JP; Duan JA
Bioorg Med Chem; 2015 Nov; 23(21):6875-84. PubMed ID: 26455656
[TBL] [Abstract][Full Text] [Related]
20. Study on metabolism of scutellarin in rats by HPLC-MS and HPLC-NMR.
Zhang JL; Che QM; Li SZ; Zhou TH
J Asian Nat Prod Res; 2003 Dec; 5(4):249-56. PubMed ID: 14604233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
